cosibelimab
fortress,tg therapeutics,Checkpoint Therapeutics 
['cosibelimab', 'pivotal']
$ckpt checkpoint therapeutics announces presentation of pivotal trial results of cosibelimab at the 2022 american society of clinical oncology (asco) annual meeting 
Free Stock Market News are delayed 15 sec. Full features and live news available here: https://t.co/fWRacb3Vft